Crispina Calsada insider trades
Open-market stock purchases and sales by Crispina Calsada, Chief Financial Officer at Regulus Therapeutics Inc, from SEC Form 4 filings since Aug 30, 2019.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- RGLS Regulus Therapeutics Inc: 3 sales, last Jun 25, 2025